Probiotics and Belsomra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Probiotics (yogurt) and Belsomra (suvorexant). Common drug interactions include vomiting among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Probiotics and Belsomra. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Probiotics?

Probiotics has active ingredients of yogurt. It is often used in irritable bowel syndrome. eHealthMe is studying from 9,541 Probiotics users. Check the latest studies of Probiotics.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

On Jul, 25, 2026

34 people who take Probiotics and Belsomra together, and have interactions are studied.

Probiotics and Belsomra drug interactions.

What are the common drug interactions of Probiotics and Belsomra, by gender? *:

female:

Vomiting
Herpes zoster
Inflammation
Lung disorder (lung disease)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Onychoclasis (breaking of the nails)
Pain
Scleroderma (hard skin)
Skin discolouration (change of skin colour)
Urinary tract infection

male:

Diarrhoea
Face oedema (swelling of face)
Staphylococcal infection (an infection with staphylococcus bacteria)
Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
Swelling face
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrointestinal infection (infection of stomach and intestine)
Headache (pain in head)
Hepatic enzyme increased
Hypersomnia (excessive daytime sleepiness (eds))

What are the common drug interactions of Probiotics and Belsomra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)

40-49:

Breast cancer female
Fibromyalgia (a long-term condition which causes pain all over the body)
Hot flush (sudden feelings of heat)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Nausea (feeling of having an urge to vomit)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Somnambulism (sleep walking)
Therapeutic response unexpected
Vomiting
Headache (pain in head)

50-59:

Drug ineffective
Nightmare (unpleasant dream)

60+:

Cellulitis (infection under the skin)
Herpes zoster
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Burning sensation
Cataract (clouding of the lens inside the eye)
Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Dizziness
Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
Erythema (redness of the skin)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 12 people, 35.29%
Primary Immunodeficiency Syndrome: 7 people, 20.59%
Drowsiness: 7 people, 20.59%
Infection: 5 people, 14.71%
Sleep Disorder: 3 people, 8.82%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.82%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 8.82%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Probiotics and Belsomra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously